Swiss drugmaker Roche on Tuesday won approval in Japan for Rozlytrek as the world's biggest maker of cancer drugs pushes ahead in personalized medicines that require a biomarker test to identify prospective patients.
Original Article: Roche wins Japan approval for personalized cancer drug Rozlytrek